Annotation Detail

Information
Associated Genes
HIF1A
Associated Variants
HIF1A EXPRESSION
HIF1A EXPRESSION
Associated Disease
renal cell carcinoma
Source Database
CIViC Evidence
Description
Immunohistochemical staining was performed on 65 patients for HIF1A such that 23 were considered responders and 42 were considered non-responders. There was no difference between the two groups with regards to overall response rate to pazopanib. There was no difference between the two groups with regards to progression free survival.
Variant Origin
N/A
Variant Origin
N/A
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1674
Gene URL
https://civic.genome.wustl.edu/links/genes/2596
Variant URL
https://civic.genome.wustl.edu/links/variants/660
Rating
2
Evidence Type
Predictive
Disease
Renal Cell Carcinoma
Evidence Direction
Does Not Support
Drug
Pazopanib
Evidence Level
B
Clinical Significance
N/A
Pubmed
23881929
Drugs
Drug NameSensitivitySupported
PazopanibN/Afalse